Health Lecanemab Treatment Alters Plasma Biomarkers in Alzheimer’s Patients
Lecanemab treatment alters plasma biomarkers in patients with early symptomatic Alzheimer's disease, driving some molecular concentrations toward those seen in healthy individuals while pushing others in abnormal directions, neurologyadvisor.com reported. Researchers evaluated 130 plasma…